| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
AzurRx BioPharma (NASDAQ:AZRX) shares are trading higher after the company announced it will acquire First Wave Bio.
AzurRx BioPharma's stock has been rising Tuesday, up 3.66% to a price of $4.25. The stock's volume is currently 11.06 million, which is roughly 1510.74% of its recent 30-day volume average of 732.10 thousand.
The 50-day moving average price of AzurRx BioPharma's stock was $0.71 when this article was published. The stock reached a high of $5.5 and a low of $0.52 in the past 52 weeks.
Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.
Posted In: AZRX
